Before The Bell
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Ardea Biosciences Inc. (RDEA) Set A New High Following Merger Announcement

4/24/2012 6:31 AM ET

AstraZeneca (AZN: Quote) announced Monday morning that it agreed to acquire Ardea Biosciences Inc. (RDEA: Quote) for $32 per share, or approximately $1.26 billion.

Ardea Biosciences gapped open dramatically higher Monday, but traded in a narrow range throughout the session. Shares finished up by 10.78 at $31.62 on the highest volume of the year. The stock surged to a new high for the year.

Click here to receive FREE breaking news email alerts for ARDEA BIOSCIENCES and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

comments powered by Disqus